- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/22 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
Patent holdings for IPC class C07D 473/22
Total number of patents in this class: 18
10-year publication summary
|
2
|
0
|
0
|
1
|
1
|
0
|
2
|
4
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2814 |
5 |
| The Regents of the University of California | 20745 |
2 |
| AstraZeneca UK Limited | 528 |
2 |
| Syntara Limited | 11 |
2 |
| Board of Regents, The University of Texas System | 6107 |
1 |
| NovaCardia, Inc. | 3 |
1 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
1 |
| Bioventures, LLC | 238 |
1 |
| Hepo Pharmaceutical Co., Ltd | 1 |
1 |
| Marvel Biotechnology | 12 |
1 |
| Inversago Pharma Inc. | 7 |
1 |
| Other owners | 0 |